Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer. (2025). Bangladesh Journal of Medical Physics, 16(2), 56-64. https://doi.org/10.3329/bjmp.v16i2.84807